These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20691149)

  • 1. The multidrug resistance half-transporter ABCG2 is purified as a tetramer upon selective extraction from membranes.
    Dezi M; Fribourg PF; Di Cicco A; Arnaud O; Marco S; Falson P; Di Pietro A; Lévy D
    Biochim Biophys Acta; 2010 Nov; 1798(11):2094-101. PubMed ID: 20691149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2.
    McDevitt CA; Collins RF; Conway M; Modok S; Storm J; Kerr ID; Ford RC; Callaghan R
    Structure; 2006 Nov; 14(11):1623-32. PubMed ID: 17098188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein.
    Telbisz Á; Özvegy-Laczka C; Hegedűs T; Váradi A; Sarkadi B
    Biochem J; 2013 Mar; 450(2):387-95. PubMed ID: 23205634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity.
    Xu J; Peng H; Chen Q; Liu Y; Dong Z; Zhang JT
    Cancer Res; 2007 May; 67(9):4373-81. PubMed ID: 17483351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
    Ozvegy C; Litman T; Szakács G; Nagy Z; Bates S; Váradi A; Sarkadi B
    Biochem Biophys Res Commun; 2001 Jul; 285(1):111-7. PubMed ID: 11437380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system.
    Wakabayashi K; Nakagawa H; Adachi T; Kii I; Kobatake E; Kudo A; Ishikawa T
    J Exp Ther Oncol; 2006; 5(3):205-22. PubMed ID: 16528971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
    Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detergent-free purification of ABC (ATP-binding-cassette) transporters.
    Gulati S; Jamshad M; Knowles TJ; Morrison KA; Downing R; Cant N; Collins R; Koenderink JB; Ford RC; Overduin M; Kerr ID; Dafforn TR; Rothnie AJ
    Biochem J; 2014 Jul; 461(2):269-78. PubMed ID: 24758594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane dynamics and tetrameric organisation of ABCG2 transporters in mammalian cells revealed by single particle imaging techniques.
    Wong K; Briddon SJ; Holliday ND; Kerr ID
    Biochim Biophys Acta; 2016 Jan; 1863(1):19-29. PubMed ID: 26453803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of homogeneous and active ABCG2 in insect cells.
    Pozza A; Pérez-Victoria JM; Di Pietro A
    Protein Expr Purif; 2009 Feb; 63(2):75-83. PubMed ID: 18977303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter.
    Telbisz A; Müller M; Ozvegy-Laczka C; Homolya L; Szente L; Váradi A; Sarkadi B
    Biochim Biophys Acta; 2007 Nov; 1768(11):2698-713. PubMed ID: 17662239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2.
    Xu J; Liu Y; Yang Y; Bates S; Zhang JT
    J Biol Chem; 2004 May; 279(19):19781-9. PubMed ID: 15001581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the central tyrosines of putative cholesterol recognition amino acid consensus (CRAC) sequences modify folding, activity, and sterol-sensing of the human ABCG2 multidrug transporter.
    Gál Z; Hegedüs C; Szakács G; Váradi A; Sarkadi B; Özvegy-Laczka C
    Biochim Biophys Acta; 2015 Feb; 1848(2):477-87. PubMed ID: 25445676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions.
    Glavinas H; Kis E; Pál A; Kovács R; Jani M; Vági E; Molnár E; Bánsághi S; Kele Z; Janáky T; Báthori G; von Richter O; Koomen GJ; Krajcsi P
    Drug Metab Dispos; 2007 Sep; 35(9):1533-42. PubMed ID: 17537873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insect cell versus bacterial overexpressed membrane proteins: an example, the human ABCG2 transporter.
    Pozza A; Pérez-Victoria JM; Di Pietro A
    Methods Mol Biol; 2010; 654():47-75. PubMed ID: 20665261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and structural analyses of ABCG2.
    McDevitt CA; Collins R; Kerr ID; Callaghan R
    Adv Drug Deliv Rev; 2009 Jan; 61(1):57-65. PubMed ID: 19124053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.
    Telbisz Á; Hegedüs C; Váradi A; Sarkadi B; Özvegy-Laczka C
    Drug Metab Dispos; 2014 Apr; 42(4):575-85. PubMed ID: 24384916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions.
    Saito H; Hirano H; Nakagawa H; Fukami T; Oosumi K; Murakami K; Kimura H; Kouchi T; Konomi M; Tao E; Tsujikawa N; Tarui S; Nagakura M; Osumi M; Ishikawa T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1114-24. PubMed ID: 16489126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of interaction between tauroursodeoxycholate and ATP-binding cassette transporter isoform G2 (ABCG2).
    Vaidya SS; Gerk PM
    Mol Pharm; 2006; 3(3):303-6. PubMed ID: 16749862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.
    Ozvegy-Laczka C; Köblös G; Sarkadi B; Váradi A
    Biochim Biophys Acta; 2005 Feb; 1668(1):53-63. PubMed ID: 15670731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.